
The Free Thought Project October 6, 2021 Spread the love
(ZH) — Merck’s new ‘not Ivermectin’ Covid-19 treatment, molnupiravir, costs $17.74 to produce– yet the company is charging the US government$712 for the treatment– a 40x markup, according toThe Intercept, citing areportissued last week by the Harvard School of Public Health and King’s College Hospital in London.

How to Get Ivermectin: see HERE:… HOW TO BEAT COVID: see https://covid19criticalcare.com/
The pill, originally developed using US government funds as a possible treatment for Venezuelan equine encephalitis, “cut the risk of hospitalization and death” in half in a randomized trial of 775 adults with mild/moderate Covid who were considered at high risk…
View original post 165 more words

